Larsen & Toubro, India’s leading technology, engineering, construction, manufacturing and financial services conglomerate, is committed to participate in corporate India’s response to COVID-19 through funds, community welfare plans and by leveraging its expertise to offer assistance. 

Strides Pharma Science Limited has received an establishment inspection report (EIR) for the inspection conducted by United States Food & Drug Administration (USFDA) in January 2020 at its flagship facility (KRS Gardens) in Bengaluru thereby, confirming the successful closure of the inspections.

TVS Motor Company, which is a two-wheeler and three-wheeler manufacturer, along with die-caster Sundaram-Clayton Ltd (SCL), together announced spending of around Rs 30 crore for supporting the efforts to curb the spread of COVID-19.

The market opened in the red on March 30, 2020, overall volumes in futures & options currently stand at 77.45 lakh contracts with a turnover of Rs. 4,29,040.68 crore.

The market opened in the red on March 30, 2020, overall volumes in futures & options currently stand at 77.45 lakh contracts with a turnover of Rs. 4,29,040.68 crore.

The market opened in the red on March 30, 2020. The previous trading session witnessed the Sensex going down by 131.18 points to end at 29,815.59 and the Nifty was up 18.80 points to close at 8,660.25.

The market opened in the red on March 30, 2020. The previous trading session witnessed the Sensex going down by 131.18 points to end at 29,815.59 and the Nifty was up 18.80 points to close at 8,660.25.

The high to low range of the last week becomes crucial which stands at 7,511 to 9,039 levels. As long as we stay within this range, we can expect the markets to consolidate. Stocks in news: Sun Pharmaceutical, Motherson Sumi systems, Manappuram Finance, NTPC, Delta Corp, Lupin and Laurus Labs.

Welcome to the fresh week on D-Street! The markets ended the last trading session near the day’s low and gave away the entire decent gains post RBI announcement. Over the weekend, if market participants were hoping for some Monday Magic to revive the sentiments on D-Street, which lost its pace after RBI announcement then, they will be certainly disappointed.

Aurobindo Pharma gained around 12 per cent to Rs 406 on Friday after the company informed that it has received an EIR from USFDA for its Hyderabad facility. The company also informed that it has received USFDA approval for its muscle relaxant-Tizanidine Hydrochloride. Soon after this approval, the stock hit an upper circuit of Rs 397.50 per share.